N-[2-[di(propan-2-yl)amino]ethyl]-2-[1-[6-(3,4,5-trimethoxyanilino)pyridazin-3-yl]indol-3-yl]acetamide
C31H40N6O4 — CID 117086666
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[di(propan-2-yl)amino]ethyl]-2-[1-[6-(3,4,5-trimethoxyanilino)pyridazin-3-yl]indol-3-yl]acetamide
N-[2-[di(propan-2-yl)amino]ethyl]-2-[1-[6-(3,4,5-trimethoxyanilino)pyridazin-3-yl]indol-3-yl]acetamide (PubChem CID 117086666) has the molecular formula C31H40N6O4 and a molecular weight of 560.70 g/mol. Its IUPAC name is N-[2-[di(propan-2-yl)amino]ethyl]-2-[1-[6-(3,4,5-trimethoxyanilino)pyridazin-3-yl]indol-3-yl]acetamide.
Molecular Properties
| Compound Name | N-[2-[di(propan-2-yl)amino]ethyl]-2-[1-[6-(3,4,5-trimethoxyanilino)pyridazin-3-yl]indol-3-yl]acetamide |
|---|---|
| PubChem CID | 117086666 |
| Molecular Formula | C31H40N6O4 |
| Molecular Weight | 560.70 g/mol |
| Exact Mass | 560.31 |
| IUPAC Name | N-[2-[di(propan-2-yl)amino]ethyl]-2-[1-[6-(3,4,5-trimethoxyanilino)pyridazin-3-yl]indol-3-yl]acetamide |
| SMILES | COc1cc(Nc2ccc(-n3cc(CC(=O)NCCN(C(C)C)C(C)C)c4ccccc43)nn2)cc(OC)c1OC |
| InChI | InChI=1S/C31H40N6O4/c1-20(2)36(21(3)4)15-14-32-30(38)16-22-19-37(25-11-9-8-10-24(22)25)29-13-12-28(34-35-29)33-23-17-26(39-5)31(41-7)27(18-23)40-6/h8-13,17-21H,14-16H2,1-7H3,(H,32,38)(H,33,34) |
| InChIKey | KYKLOSDJYYYMPV-UHFFFAOYSA-N |
| XLogP | 4.97 |
| TPSA | 102.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 560.70 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117086666 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.